The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease

被引:2
|
作者
Coban, Melahat [1 ]
Inci, Ayca [1 ]
机构
[1] Antalya Training & Res Hosp, Div Nephrol, Antalya, Turkey
关键词
Autosomal dominant polycystic kidney disease; Angiopoietin; Vascular endothelial growth factor; Total kidney volume; Renal failure; VOLUME PROGRESSION; VEGF; ADPKD; ANGIOPOIETIN-2; HYPERTENSION; CONSORTIUM; EXPRESSION; REGRESSION; SEVERITY; CRISP;
D O I
10.1007/s11255-018-1866-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Autosomal dominant polycystic kidney disease (ADPKD) is a common congenital chronic kidney disease (CKD). We report here the relationship of serum angiopoietin-1 (Ang-1), Ang-2, and vascular endothelial growth factor (VEGF) with total kidney volume (TKV), total cyst volume (TCV), and renal failure in adult ADPKD patients at various stages of CKD. This cross-sectional study was conducted with 50 patients diagnosed with ADPKD and a control group of 45 age-matched healthy volunteers. In patient group, TKV and TCV were determined with upper abdominal magnetic resonance imaging, whereas in controls, TKV was determined with ultrasonography according to ellipsoid formula. Renal function was assessed with serum creatinine, estimated glomerular filtration rate (eGFR), and spot urinary protein/creatinine ratio (UPCR). Ang-1, Ang-2, and VEGF were measured using enzyme-linked immunosorbent assay. Patients with ADPKD had significantly higher TKV (p < 0.001) and UPCR (p < 0.001), and lower eGFR (p ae<currency> 0.001) compared to the controls. Log(10)Ang-2 was found to be higher in ADPKD patients at all CKD stages. Multiple linear regression analysis showed that there was no association between log(10)Ang-1, log(10)Ang-2, or log(10)VEGF and creatinine, eGFR, UPCR, log(10)TKV (p > 0.05). There was no association of serum angiogenic growth factors with TKV or renal failure in ADPKD patients. Increased serum Ang-2 observed in stages 1-2 CKD suggests that angiogenesis plays a role in the progression of early stage ADPKD, but not at later stages of the disease. This may be explained by possible cessation of angiogenesis in advanced stages of CKD due to the increased number of sclerotic glomeruli.
引用
收藏
页码:1293 / 1300
页数:8
相关论文
共 50 条
  • [21] The relationship between renal volume and renal function in autosomal dominant polycystic kidney disease
    Shino Tokiwa
    Satoru Muto
    Toshiyuki China
    Shigeo Horie
    Clinical and Experimental Nephrology, 2011, 15 : 539 - 545
  • [22] The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease
    Tomoyuki Kawada
    Clinical and Experimental Nephrology, 2016, 20 : 147 - 148
  • [23] Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study
    Fick-Brosnahan, GM
    Belz, MM
    McFann, KK
    Johnson, AM
    Schrier, RW
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (06) : 1127 - 1134
  • [24] The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease
    Kawada, Tomoyuki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (01) : 147 - 148
  • [25] Nutritional Status is Associated With Preserved Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease
    Lee, Jinwoo
    Ryu, Hyunjin
    Kim, Yong-Chul
    Park, Hayne Cho
    Ahn, Curie
    Lee, Kyu-Beck
    Kim, Yeong Hoon
    Kim, Yaerim
    Han, Seungyeop
    Bae, Eun Hui
    Oh, Kook-Hwan
    Oh, Yun Kyu
    JOURNAL OF RENAL NUTRITION, 2023, 33 (04) : 529 - 537
  • [26] Renal disease progression in autosomal dominant polycystic kidney disease
    Eiji Higashihara
    Shigeo Horie
    Satoru Muto
    Toshio Mochizuki
    Saori Nishio
    Kikuo Nutahara
    Clinical and Experimental Nephrology, 2012, 16 : 622 - 628
  • [27] Chronic kidney disease progression in patients with autosomal dominant polycystic kidney disease
    Panizo, Nayara
    Goicoechea, Marian
    Garcia de Vinuesa, Soledad
    Arroyo, David
    Yuste, Claudia
    Rincon, Abraham
    Verdalles, Ursula
    Ruiz-Caro, Caridad
    Quiroga, Borja
    Luno, Jose
    NEFROLOGIA, 2012, 32 (02): : 197 - 205
  • [28] Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease
    Messchendorp, A. Lianne
    Spithoven, Edwin M.
    Casteleijn, Niek F.
    Dam, Wendy A.
    van den Born, Jacob
    Tonnis, Wouter F.
    Gaillard, Carlo A. J. M.
    Meijer, Esther
    Drenth, Joost
    de Fijter, Johan W.
    Gansevoort, Ron T.
    Peters, Dorien J. M.
    Wetzels, Jack F. M.
    Zietse, Robert
    BMC NEPHROLOGY, 2018, 19
  • [29] Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
    Serra, Andreas L.
    Poster, Diane
    Kistler, Andreas D.
    Krauer, Fabienne
    Raina, Shagun
    Young, James
    Rentsch, Katharina M.
    Spanaus, Katharina S.
    Senn, Oliver
    Kristanto, Paulus
    Scheffel, Hans
    Weishaupt, Dominik
    Wuethrich, Rudolf P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) : 820 - 829
  • [30] Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease
    Ozkurt, Sultan
    Dogan, Ibrahim
    Ozcan, Oguzhan
    Fidan, Nurdan
    Bozaci, Ilter
    Yilmaz, Behice
    Bilgin, Muzaffer
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (07) : 1191 - 1197